ResearcherHFR Freiburg KantonsspitalActive in the last 2 years
Claudia Mellenthin
Matched on ORCID iD 0000-0002-1159-6829; OpenAlex author ID A5073844372. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 10
2021: 1 paper · 2022: 1 paper · 2023: none · 2024: none · 2025: 2 papers
Papers 4
- Performance of the EndPAC risk score for pancreatic cancer in new onset diabetes patients with missing data - a database study in the British population. Co-author DOI 10.1016/j.pan.2025.09.017↗
- IL-6/GP130/JAK/STAT3 Pathway Activation in Pancreatic Ductal Adenocarcinoma and Its Association With Clinical Features: Protocol for a Retrospective Cross-Sect… Co-author DOI 10.2196/76811↗
- Risk Factors for Pancreatic Cancer in Patients with New-Onset Diabetes: A Systematic Review and Meta-Analysis. Co-author DOI 10.3390/cancers14194684↗
- Therapeutic targeting of STAT3 pathways in pancreatic adenocarcinoma: A systematic review of clinical and preclinical literature. First author DOI 10.1371/journal.pone.0252397↗
Closest collaborators
The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Cornelia Schneider · 2 shared papers, 2025 · strength 0.55
- Paper Performance of the EndPAC risk score for pancreatic cancer in new onset diabetes patients with missing data - a databas… DOI 10.1016/j.pan.2025.09.017↗
- Paper IL-6/GP130/JAK/STAT3 Pathway Activation in Pancreatic Ductal Adenocarcinoma and Its Association With Clinical Features:… DOI 10.2196/76811↗
- Sarah Peisl · 2 shared papers, 2021–2025 · strength 0.40
- Paper IL-6/GP130/JAK/STAT3 Pathway Activation in Pancreatic Ductal Adenocarcinoma and Its Association With Clinical Features:… DOI 10.2196/76811↗
- Paper Therapeutic targeting of STAT3 pathways in pancreatic adenocarcinoma: A systematic review of clinical and preclinical l… DOI 10.1371/journal.pone.0252397↗
- Léo Bühler · 2 shared papers, 2021–2025 · strength 0.40
- Paper IL-6/GP130/JAK/STAT3 Pathway Activation in Pancreatic Ductal Adenocarcinoma and Its Association With Clinical Features:… DOI 10.2196/76811↗
- Paper Therapeutic targeting of STAT3 pathways in pancreatic adenocarcinoma: A systematic review of clinical and preclinical l… DOI 10.1371/journal.pone.0252397↗
- Christoph Rudolf Meier · 1 shared paper, 2025 · strength 0.30
- Léo H. Bühler · 1 shared paper, 2025 · strength 0.30
- Iréne Esposito · 1 shared paper, 2025 · strength 0.25
- Ana Dugic · 1 shared paper, 2022 · strength 0.22
- Stéphane Cullati · 1 shared paper, 2022 · strength 0.22
- Daniel Vasile Balaban · 1 shared paper, 2022 · strength 0.22
- Bernhard Egger · 1 shared paper, 2021 · strength 0.16
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.